 Connection
Nicholas Foreman to Clinical Trials as Topic
This is a "connection" page, showing publications Nicholas Foreman has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.159 |
|
|
|
-
Gajjar A, Packer RJ, Foreman NK, Cohen K, Haas-Kogan D, Merchant TE. Children's Oncology Group's 2013 blueprint for research: central nervous system tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):1022-6.
Score: 0.066
-
Hansford JR, Bouche G, Ramaswamy V, Jabado N, Fonseca A, Moloney S, Gottardo NG, Robinson GW, Gajjar A, Tinkle CL, Fisher PG, Foreman N, Ashley DM, Ziegler DS, Eisenstat DD, Massimino M, Witt O, Bartels U, Rutkowski S, Hargrave D, Fouladi M, Pfister SM, Bouffet E. Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201. J Clin Oncol. 2024 12 10; 42(35):4126-4129.
Score: 0.037
-
Foreman NK, Thorne RN, Mott MG. Variation in survival of children with cancer within a region of the United Kingdom. Cancer. 1996 Feb 15; 77(4):785-90.
Score: 0.020
-
Thorne R, Foreman NK. Central nervous system tumours lack national studies. Arch Dis Child. 1994 Jul; 71(1):95-6.
Score: 0.018
-
Mulcahy Levy JM, Foreman NK, Thorburn A. Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors. Autophagy. 2014; 10(11):2077-8.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|